reports
Qatar National Navigation & Transport Co: 1 director
A director at Qatar National Navigation & Transport Co bought 10,000 shares at 0.000QAR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate...
Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancer Licensing deal reflects Hepion’s strategic shift to advancing clinically proven liquid biopsy tests under new leadership MORRISTOWN, N.J., March 03, 2026 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a precision diagnostics company, today announced that it has in-licensed from Cirna Diagnostics LLC, a novel biomarker assay ...
MSP Steel & Power Ltd: 1 director
A director at MSP Steel & Power Ltd bought 3,192,500 shares at 32.198INR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
SIGA to Host Business Update Call on March 10, 2026, Following Release...
SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, March 10, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Rel...
Lexeo Therapeutics to Participate in the Leerink Global Healthcare Con...
Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that the Company will participate in a fireside chat at the Leerink Global Healthcare Conference on Tuesday, March 10, 2026 at 10:00 a.m. ET in Miami, FL. The event will be webcast live under the tab in the Investors section of the Company’s website. A replay of the webcast will be available on the Lexeo website following t...
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Foru...
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum HOLLISTON, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that John Duke, President and Chief Executive Officer, and Mark Frost, Interim Chief Financial Officer, will be participating in KeyBanc Capital Markets’ Virtual Healthcare Forum on Tuesday, March 17th. A fireside chat will be broadcast from the company’s at 2:15pm ET that day. Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website . About...
Saia Provides January and February LTL Operating Data
Saia Provides January and February LTL Operating Data JOHNS CREEK, Ga., March 03, 2026 (GLOBE NEWSWIRE) -- Saia, Inc. (Nasdaq: SAIA), a leading transportation provider offering national less-than-truckload (LTL), non-asset truckload, expedited and logistics services, is providing LTL shipment and tonnage data for the first two months of the first quarter. In January 2026, LTL shipments per workday declined 2.1%, LTL tonnage per workday declined 7.0% and LTL weight per shipment declined 5.1%, in each case compared to January 2025. In February 2026, LTL shipments per workday increased 0.3%,...
Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financ...
Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 FORT WORTH, TX, March 03, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, announced today that it will report its fourth quarter and full year 2025 financial results on Tuesday, March 24, 2026 before the U.S. financial markets open. The Company wi...
L.B. Foster Company Finishes 2025 with Highest Fourth Quarter Net Sale...
L.B. Foster Company Finishes 2025 with Highest Fourth Quarter Net Sales since 2018, Delivering Strong Profitability Growth and Operating Cash Flow Fourth quarter net sales totaled $160.4 million, up 25.1% over last year with increases of 23.7% in Rail and 27.3% in Infrastructure, both driven by strong improvements in North American demand. Fourth quarter net income of $2.4 million was favorable $2.6 million versus last year; Adjusted EBITDA1 of $13.7 million increased $6.4 million, or 89.0%, versus last year; Selling and administrative expenses as a percentage of sales were 14.4% for the qu...
Medicus Pharma To Participate in the 38th Annual Roth Conference
Medicus Pharma To Participate in the 38th Annual Roth Conference Company Exec. Chairman & CEO in a fireside chat is expected to highlight the role of Skinject in an autosomal dominant rare disease, AI-enabled drug development strategy and partnering readiness PHILADELPHIA, March 03, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce it will be participating in the 38th Annual Roth Con...
ZenaTech’s ZenaDrone Advances U.S. Defense and Congressional Engagemen...
ZenaTech’s ZenaDrone Advances U.S. Defense and Congressional Engagement with Blue UAS-Aligned Drone Development VANCOUVER, British Columbia, March 03, 2026 (GLOBE NEWSWIRE) -- In light of current international events, ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, today provides an update on its plans to advance engagement within the U.S. defense ecosystem and with Congressional representatives in Washington, D....
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvogura...
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026 Presentations include three-year follow-up data from patients receiving a one-time 50 milligram (mg) dose of lonvo-z and survey findings highlighting patients’ continued treatment burden and unmet needs CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, ...
Anavex Life Sciences to Present at the Citizens Life Sciences Conferen...
Anavex Life Sciences to Present at the Citizens Life Sciences Conference NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that Christopher U Missling, PhD, President & Chief Executive Officer, will present at the Citizens Life Scie...
Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025...
Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference CLEVELAND, March 03, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it will host a conference call on Tuesday, March 17, 2026 at 8:30 a.m. ET to discuss its fourth quarter and full year 2025 financial results and corporate progress. The conference call will be available via phone and webcast. To access the call, dial 888-506-0062 (U.S. toll-free) or 973-528-0011 (international) and Entry Code: 97...
Streamex Corp. Appoints Shawn Matthews, Former CEO of Cantor Fitzgeral...
Streamex Corp. Appoints Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. & Founder and CIO of Hondius Capital Management, to Board of Directors WINTER PARK, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today is excited to announce the appointment of Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. and Founder and Chief Investment Officer of Hondius Capital Management, to its Board of Directors. In this role, Mr. Matthews will bring decades of gl...
Olenox Industries Kicks Off 2026 with 10-Well Drilling Program
Olenox Industries Kicks Off 2026 with 10-Well Drilling Program Relicensing of Company’s 162-mile pipe is also proceeding CONROE, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- via IBN -- (NASDAQ: OLOX) (“Olenox” or the “Company”), a multifaceted energy company, is pleased to announce its 2026 drilling program is underway with the identification of well locations and plans to begin shooting seismic data this month. Olenox’s plans include drilling one well by the end of the current calendar quarter, followed by drilling three wells in each of the second, third and fourth calendar quarters of ...
HAOXI HEALTH TECHNOLOGY and Eaglepoint AI Forge Strategic Partnership ...
HAOXI HEALTH TECHNOLOGY and Eaglepoint AI Forge Strategic Partnership to Enter AI-Powered Health Management Track BEIJING, March 03, 2026 (GLOBE NEWSWIRE) -- HAOXI HEALTH TECHNOLOGY LIMITED (NASDAQ: HAO) (the “Haoxi Health”), a U.S. publicly listed company, and Eaglepoint AI Inc., a subsidiary of Global Mofy AI Limited (NASDAQ: GMM), today jointly announced the signing of a three-year strategic cooperation agreement. The two parties will jointly commit R&D, data, and channel resources to launch an AI health management platform in China. Haoxi Health believes that this partnership marks it...
Jelly Toast Launches in India to Simplify Everyday Celebrations
Jelly Toast Launches in India to Simplify Everyday Celebrations A new app from Synchronoss designed to simplify how people celebrate and share memories BRIDGEWATER, N.J. and BANGALORE, India, March 03, 2026 (GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”), a global leader and innovator in personal cloud platforms, today announced the launch of Jelly Toast in India, a new app designed for shared celebrations and group memories. From birthdays and weddings to Holi gatherings, college festivals, office outings, concerts, and weekend trips, Jelly Toast cr...
Micropolis Signs $9.3 Million Commercial Development and Multi-Year Di...
Micropolis Signs $9.3 Million Commercial Development and Multi-Year Distribution Agreement with AfricAI to Expand AI-Driven Autonomous Vehicles Across Africa New agreement includes development of three custom UGV models and exclusive regional distribution rights across key African markets DUBAI, United Arab Emirates, March 03, 2026 (GLOBE NEWSWIRE) -- Micropolis Robotics (NYSE: MCRP) (“Micropolis” or the “Company”), a pioneer in unmanned ground vehicles (“UGVs”) and AI-driven autonomous mobility solutions, today announced it has signed a comprehensive commercial agreement with AfricAI L...
Director/PDMR Shareholding
Director/PDMR Shareholding ICG plc (the “Company”) 3 March 2026 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them The Company received notification that on 2 March 2026, Sonia Baxendale, Non-Executive Director, purchased 5,000 ordinary shares in the Company. The notifications set out in this announcement are disclosed in accordance with the requirements of the UK Market Abuse Regulation. 1Details of the person discharging managerial responsibilities/person closely associateda)NameSonia Baxendale...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.